Prudential subsidiaries hold 1.84M Tarsus shares (NASDAQ: TARS)

Rhea-AI Filing Summary

Prudential Financial, Inc. filed an Amendment No. 20 on Schedule 13G/A reporting beneficial ownership of 1,836,321 shares of Common Stock of Tarsus Pharmaceuticals, Inc. (4.3%) as of 03/31/2026. The filing shows shared voting power of 1,670,648 and shared dispositive power of 1,836,321. The disclosure attributes holdings to subsidiaries, including Jennison Associates LLC: 1,712,124 shares (4.0%), The Prudential Insurance Company of America: 117,972 shares (0.3%), and PGIM Quantitative Solutions LLC: 6,225 shares.

Insights

Institutional Ownership Analyst

Large institutional stake reported, dominated by Jennison Associates.

The filing records a 4.3% beneficial position held indirectly by Prudential Financial and its subsidiaries as of 03/31/2026. Jennison Associates LLC holds the majority of the disclosed position with 1,712,124 shares.

Such Schedule 13G/A amendments typically update passive ownership disclosures; cash‑flow or control changes are not indicated in the excerpt. Subsequent filings would show any changes in voting or disposition strategy.

Corporate Governance Advisor

Disclosure clarifies voting and dispositive powers across Prudential entities.

The report specifies shared voting power: 1,670,648 and shared dispositive power: 1,836,321, showing coordinated indirect holdings by multiple subsidiaries. The parent indicated it is a Parent Holding Company and identified the beneficial subsidiaries by name and share amounts.

These details matter for proxy and voting records; any material change in ownership or intent would be reflected in future amendments.

Key Figures

Beneficial ownership: 1,836,321 shares Percent of class: 4.3% Shared voting power: 1,670,648 shares +2 more

5 metrics

Beneficial ownership 1,836,321 shares as of 03/31/2026

Percent of class 4.3% ownership percentage reported

Shared voting power 1,670,648 shares voting power reported in filing

Jennison Associates holding 1,712,124 shares subsidiary amount listed

The Prudential Insurance Co. holding 117,972 shares subsidiary amount listed

Key Terms

Schedule 13G/A, Beneficially owned, Shared dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 20 ) Tarsus Pharmaceuticals, Inc."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Amount beneficially owned: 1,836,321.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power regulatory

"Shared dispositive power 1,836,321.00"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 11:21 AM Learn about SEC filing dates

FAQ

What stake does Prudential hold in TARS in this Schedule 13G/A?

Prudential reports beneficial ownership of 1,836,321 shares of Tarsus, representing 4.3% of the class as of 03/31/2026. The filing aggregates indirect holdings across Prudential subsidiaries.

Which Prudential subsidiaries hold TARS shares and how many?

The filing lists subsidiaries and amounts: Jennison Associates LLC: 1,712,124 shares (4.0%), The Prudential Insurance Company of America: 117,972 shares (0.3%), and PGIM Quantitative Solutions LLC: 6,225 shares.

Does the filing show Prudential has sole voting control of TARS shares?

No. The excerpt shows 0 shares with sole voting power. It reports shared voting power of 1,670,648 and shared dispositive power of 1,836,321 for the reported holdings.

What date does this Schedule 13G/A reporting cover for TARS ownership?

The filing identifies the reporting period date as 03/31/2026 and is signed on 05/08/2026. The ownership amounts are presented with the 03/31/2026 time anchor.

Does this Schedule 13G/A indicate any change in control or intent to influence TARS?

The amendment lists passive beneficial ownership and subsidiary breakdowns; it does not state any change in control or an intent to influence. The disclosure is presented as an ownership update.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 20)

Tarsus Pharmaceuticals, Inc.

(Name of Issuer)

Common

(Title of Class of Securities)

87650L103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 87650L103

1

Names of Reporting Persons

PRUDENTIAL FINANCIAL INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW JERSEY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,670,648.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,836,321.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,836,321.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.3 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Tarsus Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 15440 LAGUNA CANYON ROAD, IRVINE, CALIFORNIA, 92618.
Item 2.
(a)	Name of person filing: Prudential Financial, Inc.
(b)	Address or principal business office or, if none, residence: 751 Broad Street Newark, New Jersey 07102-3777
(c)	Citizenship: New Jersey
(d)	Title of class of securities: Common
(e)	CUSIP No.: 87650L103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,836,321.00
(b)	Percent of class: 4.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,670,648.00
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,836,321.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Prudential Financial, Inc. is a Parent Holding Company and the indirect parent of the following subsidiaries, who are the beneficial owners of the number and percentage of securities which are the subject of this filing as set forth next to their names: Subsidiaries Number of shares Percentage Jennison Associates LLC IA 1,712,124.00 4.0 The Prudential Insurance Company of America IC 117,972 0.3 PGIM Quantitative Solutions LLC IA 6,225.00 0.0
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

PRUDENTIAL FINANCIAL INC

Signature:	/s/ Danny Fiore
Name/Title:	Second Vice President
Date:	05/08/2026